The Effect of Beetroot Powder on Exercise Performance in Competitive Swimmers
19 de junho de 2026 atualizado por: Aysun Köktürk Bayram, Halic University
Swimming requires high energy in a short time and involves overcoming water resistance. Besides regular training, swimmers use supplements to enhance performance, correct nutrient deficiencies, and speed recovery. The Australian Institute of Sport (AIS) classifies supplements by evidence level, with nitrate in Group A. Nitrate aids vasodilation and muscle performance via conversion to nitric oxide (NO).
About 25% of dietary nitrate converts to nitrite by oral bacteria, then to NO in the stomach-a valuable oxygen-independent pathway. NO improves exercise by enhancing oxygen efficiency, muscle contraction, and affecting type II fibers. Timing, dose, nitrate source, and individual traits influence its effect. Beetroot, rich in nitrate, is practical as juice for storage and consumption.
Beetroot gels and juices raise plasma nitrate 1-3 hours post-consumption, effective during 10-17 minute exercises. Some studies found no improvement in short-distance swimming, but others reported dose-dependent benefits. Meta-analyses recommend 5-14.9 mmol nitrate ≥150 minutes before acute exercise, and 5-9.9 mmol for chronic intake. Highly trained athletes may need ≥6-8 mmol NO₃-.
JECFA and the European Commission set acceptable daily intake (ADI) at 0-3.7 mg/kg body weight nitrate ion, safe for all ages.
No long-term, controlled studies exist on beetroot powder's effect in swimmers. To address this, a randomized, placebo-controlled, triple-blind crossover study was designed to evaluate beetroot powder supplementation's impact on competitive swimmers' performance, potentially contributing valuable knowledge.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
- Study Design and Participants: This study employed a randomized, double-blind, placebo-controlled crossover design to investigate the effects of beetroot supplementation. Based on a power analysis conducted with a 5% error level and a statistical power of 0.95, a sample size of 36 participants was determined to be sufficient. The study was conducted over a one-year period at the Galatasaray Swimming Club following approval from the institutional ethics committee, and all participants provided written informed consent. Inclusion criteria required voluntary participation with parental consent, an age range of 18-24 years, participation in a structured training program for at least 18 hours per week, no history of chronic disease, no current use of sports or food supplements/medications, and no adherence to a special diet. Conversely, exclusion criteria included irregular training attendance, the presence of chronic diseases, and a failure to cease the use of food supplements one week prior to the study.
- Product Development and Standardization: Three types of beetroot powder were selected from the Turkish market and analyzed by a laboratory accredited under the TURKAK TS EN ISO/IEC 17025:2017 standard, utilizing the HPLC-DAD method in accordance with NMKL No. 165. Based on these analyses, 1.5 g of beetroot powder, corresponding to a 10 mmol nitrate intervention, was used for product development at the Haliç University Nutrition Principles Laboratory. A base mixture of water, gelatin, pectin, starch, and stevia was heated to 85-90°C for homogenization and cooled to 55-60°C. The intervention product contained 1.5 g of beetroot powder, while the placebo product included food coloring to match the visual characteristics of the intervention. Products were prepared 24 hours before each session, stored in opaque, food-safe packaging at 0-4°C, and coded by an independent researcher using a random number generator to ensure triple-blind conditions.
- Experimental Procedure and Controls: Participants were instructed to maintain their habitual dietary intake throughout the study and were provided with a list of nitrate-rich foods to avoid. To prevent interference with oral nitrate-to-nitrite reduction, participants were strictly instructed to abstain from mouthwash, chewing gum, sweets, stimulants, and alcohol on all intervention days. The study consisted of five visits. Visit 1 involved providing study information and obtaining informed consent, while Visit 2 included baseline anthropometric assessments and randomization. Visit 3 involved data collection, including food record retrieval, a standardized warm-up, a 200-m freestyle performance test, and post-test measurements of blood lactate, heart rate, and fatigue. A two-week washout period was implemented between intervention phases to eliminate potential carry-over effects, followed by Visits 4 and 5, where the crossover intervention was conducted by repeating the established testing protocols with the alternative condition.
- Data Collection: Sociodemographic and lifestyle data, including age, sex, education, nutritional habits, and training characteristics, were recorded. Anthropometric measurements included body composition via bioelectrical impedance analysis, height, BMI, and hand grip strength measured by a digital dynamometer. Performance was assessed through a 200-m maximum-effort freestyle swimming test. Physiological assessments included fingertip blood lactate concentration and heart rate (resting, maximum, and average). Finally, subjective fatigue was evaluated using the Perceived Physical and Cognitive Fatigue Scale and the Visual Analog Scale (VAS).
Tipo de estudo
Intervencional
Inscrição (Real)
21
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Kartal
-
Istanbul, Kartal, Turquia (Türkiye)
- Kartal Kosuyolu Yuksek Ihtisas EAH
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Sim
Descrição
Inclusion Criteria:
- Voluntary participation with parental consent
- Age range: 18-24 years
- Participation in a training program for at least 18 hours per week
- No history of chronic disease
- Not currently using any sports supplements, food supplements, or medications
- Not following a special diet
Exclusion Criteria:
- Irregular training participation
- Presence of chronic diseases
- Failure to cease the use of food supplements one week prior to the study
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Beetroot then Placebo
Participants in this arm will first receive 1,5 grams of beetroot powder contain jelly candy daily for 3 consecutive days.
After a 14-day washout period, they will receive placebo jelly candy daily for 3 consecutive days.
|
1.5 g of beetroot powder (equivalent to 10 mmol nitrate) administered as a jelly candy.
Color-matched, nitrate-free jelly candy.
|
|
Comparador de Placebo: Placebo then Beetroot
Participants in this arm will first receive placebo jelly candy daily for 3 consecutive days.
After a 14-day washout period, they will receive 1,5 grams of beetroot powder contain jelly candy daily for 3 consecutive days.
|
1.5 g of beetroot powder (equivalent to 10 mmol nitrate) administered as a jelly candy.
Color-matched, nitrate-free jelly candy.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in 200-meter swim performance time
Prazo: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
The duration (in seconds) required for the participant to complete a 200-meter freestyle swim, measured using a Seiko stopwatch.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Blood lactate concentration
Prazo: Immediately post-exercise on the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Blood lactate levels (mmol/L) measured from capillary blood samples collected 3 minutes after completion of 200-meter swim test.
|
Immediately post-exercise on the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Visual Analog Scale (VAS) for Perceived Fatigue
Prazo: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Participant's self-reported fatigue level assessed using a 10-cm visual analog scale, ranging from 0 (no fatigue) to 10 (extreme fatigue), completed immediately after the swim test.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Heart Rate Change
Prazo: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Maximum heart rate during the 200m swim, heart rate at 1 minute post-performance, and mean heart rate during the test, recorded using a Polar sports watch with an integrated wrist-based optical heart rate monitor.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Change in Perceived Physical and Cognitive Fatigue Scale (AFBYÖ) Scores
Prazo: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
The 19-item Perceived Physical and Cognitive Fatigue Scale (PPCFS) is a 5-point Likert-type instrument used to assess athletes' perceived fatigue levels after each training session.
The scale consists of two subscales: the Perceived Physical Fatigue (PPF) subscale, which includes the first 8 items with a total score range of 8 to 40, and the Perceived Cognitive Fatigue (PCF) subscale, which includes the remaining 11 items with a total score range of 11 to 55.
The total score of the scale ranges from 19 to 95, where higher scores in either the subscales or the total score indicate increased levels of physical and cognitive fatigue, respectively.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Daily Energy and Nutrient Intake
Prazo: Collected during the 24-hour period prior to the 3rd day of each 3-day intervention period (both beetroot or placebo supplementation).
|
Dietary intake was monitored through 24-hour dietary records kept by participants for 24 hours prior to each measurement day.
Ingredient quantities for composite dishes were calculated using the "Standard Food Recipes" manual.
Subsequently, total daily energy and nutrient intakes were analyzed and quantified using the Nutrition Information System (BeBİS) software.
|
Collected during the 24-hour period prior to the 3rd day of each 3-day intervention period (both beetroot or placebo supplementation).
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
22 de dezembro de 2025
Conclusão Primária (Real)
22 de maio de 2026
Conclusão do estudo (Real)
1 de junho de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
16 de junho de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
19 de junho de 2026
Primeira postagem (Real)
23 de junho de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
23 de junho de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
19 de junho de 2026
Última verificação
1 de maio de 2025
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- 2025-08/318
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Descrição do plano IPD
Individual participant data (IPD) will not be shared due to concerns regarding participant confidentiality and the small sample size, which may increase the risk of re-identification.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .